Non-Alcoholic Steatohepatitis: Disease Burden, Diagnosis, and Treatment

Content Type: presentation

Presenter: Zobair M. Younossi, MD, MPH, FACG

Presenter Disclosure: Research funding and/or Consultant: Gilead Sciences, Intercept, BMS, NovoNordisk, Viking, Terns, Siemens, Shionogi, AbbVie, Merck, and Novartis.

Event: ACG Virtual Grand Rounds

Release Date: 6/11/2020

Expiration Date: 6/11/2023

Objective: Describe the epidemiologic burden of NASH, the diagnostic tests for NASH and fibrosis, and the current and future treatment of NASH.